ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

February 28, 2014

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012

Agency Approves HPV Test That Detects 14 High-Risk Strains

November 25, 2011